Literature DB >> 23063263

Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Skye C Mayo1, Joseph M Herman, David Cosgrove, Nik Bhagat, Ihab Kamel, Jean-Francois H Geschwind, Timothy M Pawlik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23063263      PMCID： PMC3538376          DOI： 10.1016/j.jamcollsurg.2012.08.027

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  74 in total

Review 1.  Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.

Authors:  G Rindi; C Capella; E Solcia
Journal:  Q J Nucl Med       Date:  2000-03

Review 2.  Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges?

Authors:  Susan Tsai; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-06-25       Impact factor: 5.344

3.  Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.

Authors:  Mechteld C de Jong; Carlo Pulitano; Dario Ribero; Jennifer Strub; Gilles Mentha; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Lorenzo Capussotti; Timothy M Pawlik
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

4.  Hepatic neuroendocrine metastases: does intervention alter outcomes?

Authors:  R S Chamberlain; D Canes; K T Brown; L Saltz; W Jarnagin; Y Fong; L H Blumgart
Journal:  J Am Coll Surg       Date:  2000-04       Impact factor: 6.113

5.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

6.  Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

Authors:  A Ahmed; G Turner; B King; L Jones; D Culliford; D McCance; J Ardill; B T Johnston; G Poston; M Rees; M Buxton-Thomas; M Caplin; J K Ramage
Journal:  Endocr Relat Cancer       Date:  2009-05-20       Impact factor: 5.678

7.  Radiotherapy for pancreatic neuroendocrine tumors.

Authors:  Joseph N Contessa; Kent A Griffith; Elizabeth Wolff; William Ensminger; Mark Zalupski; Theodore S Lawrence; Edgar Ben-Josef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-26       Impact factor: 7.038

8.  Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.

Authors:  S Scigliano; R Lebtahi; F Maire; J L Stievenart; R Kianmanesh; A Sauvanet; M P Vullierme; A Couvelard; J Belghiti; P Ruszniewski; D Le Guludec
Journal:  Endocr Relat Cancer       Date:  2009-05-26       Impact factor: 5.678

9.  Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

Authors:  Mechteld C de Jong; Skye C Mayo; Carlo Pulitano; Serena Lanella; Dario Ribero; Jennifer Strub; Catherine Hubert; Jean-François Gigot; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452

10.  Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Authors:  D Elias; D Goéré; G Leroux; C Dromain; S Leboulleux; Th de Baere; M Ducreux; E Baudin
Journal:  Eur J Surg Oncol       Date:  2009-05-21       Impact factor: 4.424
View more
  17 in total

1.  Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.

Authors:  Yuhree Kim; Neda Amini; Ana Wilson; Georgios A Margonis; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Kenneth Cardona; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-05-11       Impact factor: 5.344

2.  Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

Authors:  Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Yi Lv; Fabio Bagante; Luca Aldrighetti; George A Poultsides; Todd W Bauer; Ryan C Fields; Shishir Kumar Maithel; Hugo P Marques; Matthew Weiss; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-20       Impact factor: 3.452

Review 3.  Liver transplantation for metastatic neuroendocrine tumors.

Authors:  Louise Barbier; Cindy Neuzillet; Safi Dokmak; Alain Sauvanet; Philippe Ruszniewski; Jacques Belghiti
Journal:  Hepat Oncol       Date:  2014-12-11

4.  Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.

Authors:  Jill K Onesti; Lawrence A Shirley; Neil D Saunders; Gail W Davidson; Mary E Dillhoff; Hooman Khabiri; Gregory E Guy; Joshua D Dowell; Carl R Schmidt; Manisha H Shah; Mark Bloomston
Journal:  J Gastrointest Surg       Date:  2015-10-21       Impact factor: 3.452

Review 5.  Update in the Therapy of Advanced Neuroendocrine Tumors.

Authors:  Inbal Uri; Shani Avniel-Polak; David J Gross; Simona Grozinsky-Glasberg
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

Review 6.  Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.

Authors:  Sayee Sundar Alagusundaramoorthy; Roberto Gedaly
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.

Authors:  Gunjan S Desai; Prasad Pande; Verushka Chhabra; Rajiv C Shah; Palepu Jagannath
Journal:  Indian J Gastroenterol       Date:  2019-12-04

8.  Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.

Authors:  Gaya Spolverato; Fabio Bagante; Luca Aldrighetti; George Poultsides; Todd W Bauer; Ryan C Field; Hugo P Marques; Matthew Weiss; Shishir K Maithel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

9.  Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.

Authors:  Nancy Sharma; Boris G Naraev; Eric G Engelman; M Bridget Zimmerman; David L Bushnell; Thomas M OʼDorisio; M Sue OʼDorisio; Yusuf Menda; Jan Müller-Brand; James R Howe; Thorvardur R Halfdanarson
Journal:  Pancreas       Date:  2017-02       Impact factor: 3.327

Review 10.  Zollinger-Ellison syndrome: recent advances and controversies.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.